Egbert Oosterwijk
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Radiopharmaceutical Chemistry and Applications 38
- Monoclonal and Polyclonal Antibodies Research 27
-
- Renal cell carcinoma treatment 62
- Co-authors
- Otto C. Boerman (59 shared papers)Peter F.A. Mulders (49 shared papers)Wim J.G. Oyen (36 shared papers)Stefan Sleijfer (7 shared papers)Cor, H.J. Lamers (4 shared papers)Jeannette C. Oosterwijk‐Wakka (27 shared papers)Reno Debets (3 shared papers)Jan Willem Christiaan Gratama (3 shared papers)
- Journals
- European Urology (12 papers)British Journal of Urology (10 papers)International Journal of Cancer (10 papers)Journal of Nuclear Medicine (10 papers)The Journal of Urology (9 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Egbert Oosterwijk
274 papers receiving 11.3k citations
Egbert Oosterwijk's Hit Papers
Peers
Comparison fields: 5 of 134
- Oncology 3.3k
- Cancer Research 1.6k
- Pulmonary and Respiratory Medicine 2.5k
- Immunology 1.7k
- Radiology, Nuclear Medicine and Imaging 1.6k
Countries citing papers authored by Egbert Oosterwijk
This map shows the geographic impact of Egbert Oosterwijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egbert Oosterwijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egbert Oosterwijk more than expected).
Fields of papers citing papers by Egbert Oosterwijk
This network shows the impact of papers produced by Egbert Oosterwijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egbert Oosterwijk. The network helps show where Egbert Oosterwijk may publish in the future.
Co-authors
The 25 scholars most cited alongside Egbert Oosterwijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 278 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience Hit paper breakdown → | 2006 | 782 |
| 2 | Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity Hit paper breakdown → | 2013 | 621 |
| 3 | 2009 | 521 | |
| 4 | 2010 | 317 | |
| 5 | 2012 | 285 | |
| 6 | 2010 | 211 | |
| 7 | 2010 | 194 | |
| 8 | 2014 | 190 | |
| 9 | 2004 | 158 | |
| 10 | 2000 | 156 | |
| 11 | 1993 | 155 | |
| 12 | 2020 | 148 | |
| 13 | 2005 | 144 | |
| 14 | 2004 | 143 | |
| 15 | 1999 | 141 | |
| 16 | 1997 | 138 | |
| 17 | Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. | 1998 | 137 |
| 18 | 2004 | 125 | |
| 19 | Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. | 2004 | 122 |
| 20 | The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes. | 1999 | 119 |
About Egbert Oosterwijk
Egbert Oosterwijk is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Biomaterials, having authored 278 papers that have together received 11.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (62 papers), Tissue Engineering and Regenerative Medicine (40 papers), Radiopharmaceutical Chemistry and Applications (38 papers), Renal and related cancers (33 papers), Monoclonal and Polyclonal Antibodies Research (27 papers), Enzyme function and inhibition (25 papers), Electrospun Nanofibers in Biomedical Applications (16 papers) and Bladder and Urothelial Cancer Treatments (15 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (1.6k citations), Pulmonary and Respiratory Medicine (2.5k citations), Immunology (1.7k citations) and Radiology, Nuclear Medicine and Imaging (1.6k citations). Egbert Oosterwijk has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Otto C. Boerman, Peter F.A. Mulders, Wim J.G. Oyen, Stefan Sleijfer, Cor, H.J. Lamers, Jeannette C. Oosterwijk‐Wakka, Reno Debets, Jan Willem Christiaan Gratama, Arnold G. Vulto and Frans H.M. Corstens. Their work appears in journals such as European Urology, British Journal of Urology, International Journal of Cancer, Journal of Nuclear Medicine and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.